EFL

Cohort Year: 2024-2025

Tracks: Life Sciences

VISIT WEBSITE

Rasayana Therapeutics

Rasayana Therapeutics is utilizing the gut-organ axis to develop gut-targeted treatments for chronic diseases. Their lead candidate is a first-in-class, gut-restricted biologic that inhibits inflammation and intestinal permeability in ulcerative colitis.